Clinical Trials Browser

Phase 4 × Ovarian Neoplasms × Pharmacokinetics × Clear all

NCT04861181 2025-05-22

NIRAPK

Phase 4 Terminated

Classical hematologyGynecologic

Ovarian Neoplasms, Recurrence, Thrombocytopenia